Dr. Reddy’s plans to invest Rs 700 crore into capacity expansion of biosimilars and Active Pharmaceutical Ingredients. GV Prasad, Co-chairman and Managing Director of Dr. Reddy Laboratories shares his insights on future investments and artificial intelligence. We have seen how AI has reduced the amount of experimentation we need to do, bring more precision to our work, and give us ideas that normal human beings wouldn’t have thought about, he said while explaining how they are using machine learning to understand scaleups. For information watch this interview.
first published: Jan 15, 2024 11:02 pm
A collection of the most-viewed Moneycontrol videos.
Nifty Struggles Below 26,100 On Weekly F&O Expiry As Rupee Hits New Low| Closing Bell Live
Will Rupee Slide & Expiry Day Caution Keep Nifty Bulls On The Back Foot? | Opening Bell Live
Sensex, Nifty Retreat After Hitting Fresh Highs As Rupee Drops To Record Low| Closing Bell Live
Will Solid Q2 GDP Set The Ball Rolling For Nifty Bulls To Cross 26,300 Decisively?|Opening Bell Live
